Zonisamide is a prescription anti-seizure medication used in dogs with epilepsy, either on its own or as an add-on when another anticonvulsant does not provide enough control. It is increasingly used in canine neurology because it can be effective and is often well tolerated, but it has several distinctive safety issues owners should know about, including rare liver injury, appetite loss, urinary changes and important interactions with phenobarbital.
Dog Medication Math Calculator
Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.
Dose information from your veterinarian
Optional liquid conversion

Unlike potassium bromide, zonisamide does not take months to reach steady state. Merck Veterinary Manual notes that steady state in dogs is reached in about a week. Unlike levetiracetam, it is metabolized by the liver’s cytochrome P450 system, so phenobarbital can increase its metabolism. These differences matter in real-world treatment because the same dog may receive several anticonvulsants over time.
What zonisamide is
Zonisamide is a sulfonamide-based anticonvulsant. Its exact mechanism is not fully defined, but it appears to suppress voltage-gated sodium channels and T-type calcium channels and may also influence GABA, dopamine and serotonin signaling.
Merck Veterinary Manual reports that zonisamide has been used mainly as an adjunct medication in dogs with refractory epilepsy, but it can also be used as single-drug treatment.
Why veterinarians may choose zonisamide
A veterinarian may consider zonisamide when seizures are not controlled well enough by one drug, when adverse effects limit another medication or when a different maintenance option fits the dog’s medical history better.
It can also be used as a first-choice maintenance anticonvulsant in some dogs. The decision depends on seizure type, liver health, kidney status, concurrent medications and how much monitoring the dog can realistically receive.
What the evidence shows
Veterinary studies summarized by Merck have found meaningful seizure reductions in some dogs treated with zonisamide as add-on therapy and in some dogs receiving it as monotherapy. Response is not universal.
This is why owners should judge success by a seizure diary rather than by the assumption that a newer medication must work better than an older one.
Zonisamide versus phenobarbital
Phenobarbital has a longer history as a first-line canine maintenance anticonvulsant and has an established blood-level monitoring framework. Zonisamide has a different adverse-effect and interaction profile.
One major difference is that phenobarbital induces liver enzymes that can increase zonisamide metabolism. Merck notes that dogs receiving both may require a different zonisamide dosing approach than dogs receiving zonisamide alone. Owners should never adjust for this interaction without veterinary direction.
Zonisamide versus levetiracetam
Levetiracetam is minimally metabolized by the liver and is eliminated largely through the kidneys. Immediate-release levetiracetam also has a relatively short duration in dogs and often requires frequent dosing. Zonisamide has a longer half-life and is generally used on a different maintenance schedule.
See Levetiracetam for Dogs for the formulation and timing issues unique to that medication.
Zonisamide versus potassium bromide
Potassium bromide has a very long half-life and is strongly affected by dietary chloride. Zonisamide reaches steady state much sooner and is not managed around salt intake in the same way.
See Potassium Bromide for Dogs for the dietary and serum-monitoring issues specific to bromide.
Zonisamide dosage by weight: current canine epilepsy reference
Merck currently lists zonisamide at 5–10 mg/kg by mouth every 12 hours in dogs. It reaches steady state in about one week. Phenobarbital can increase zonisamide metabolism, which is one reason combination therapy may need a different dose within the published range.
| Reference item | Current canine guidance | Why it matters |
|---|---|---|
| Maintenance range | 5–10 mg/kg PO every 12 hours | Used as monotherapy or adjunctive antiseizure treatment |
| Steady state | About 1 week | Early dose changes should not be made from one isolated seizure alone |
| With phenobarbital | Higher end of range may be needed | Phenobarbital can increase zonisamide metabolism |
Source: Merck Veterinary Manual epilepsy guidance. Dose interpretation still depends on seizure pattern, adverse effects, other antiseizure medicines and monitoring.
Common side effects
At recommended veterinary doses, zonisamide is often well tolerated. Sedation, ataxia and reduced appetite can occur. Some dogs appear sleepy or wobbly after starting treatment or after a dose increase.
These effects may improve as the dog adapts, but persistent or severe changes deserve review. A dog that cannot walk safely or repeatedly refuses food should not simply be watched for weeks.
Why appetite loss matters
Anorexia is more than an inconvenience in a dog with epilepsy. Poor food intake can lead to dehydration, medication intolerance and metabolic instability. In small dogs or dogs with another disease, prolonged refusal to eat can become serious quickly.
Call if appetite falls markedly, especially if vomiting or lethargy is also present.
Rare liver injury
Merck Veterinary Manual notes that zonisamide, as a sulfonamide-based drug, can occasionally cause acute idiosyncratic hepatopathy in dogs. This is uncommon but important because it may not be predictable from dose alone.
Signs such as repeated vomiting, marked lethargy, appetite loss, jaundice or sudden decline deserve prompt veterinary assessment.
Why bloodwork may be recommended
Because rare liver injury and other metabolic effects can occur, a veterinarian may recommend baseline and follow-up bloodwork, especially during long-term treatment or when the dog receives higher doses or several medications.
The exact monitoring schedule varies. It should be based on the dog’s health, other anticonvulsants and clinical response.
Renal tubular acidosis and urinary stones
Merck notes that renal tubular acidosis and urinary calculi have been reported in dogs receiving zonisamide. These adverse effects are uncommon, but they are another reason persistent urinary changes should not be ignored.
Straining to urinate, blood in urine, repeated urinary accidents, pain during urination or marked changes in thirst deserve veterinary review.
Why hydration matters
Dogs with seizure disorders may become dehydrated after prolonged seizures, vomiting or poor intake. Maintaining appropriate hydration supports kidney function and may also help reduce risk in dogs prone to urinary problems.
Do not force large volumes of water into a neurologically abnormal dog because aspiration is possible. Offer normal access once the dog is fully alert.
Hypothyroidism and long-term use
Hypothyroidism has been reported as a potential adverse effect in dogs receiving zonisamide. If a dog develops unexplained weight gain, skin changes, marked lethargy or cold intolerance, the veterinarian may consider thyroid testing as part of the work-up.
These signs are nonspecific and can be caused by many other conditions, so laboratory testing is more useful than guessing.
Sulfonamide concerns
Zonisamide is structurally related to sulfonamides, but its adverse-effect pattern is not identical to every sulfonamide antibiotic. Merck notes that zonisamide lacks the arylamine group associated with some classic sulfonamide reactions such as keratoconjunctivitis sicca.
Still, tell the veterinarian about any previous severe reaction to a sulfonamide medication before starting zonisamide.
How zonisamide is given
Zonisamide is given orally. It is used extra-label in dogs, which is common in veterinary neurology. Follow the veterinary prescription rather than the human pharmacy instructions alone.
DogMedsHub does not provide an autonomous zonisamide dose calculator because weight alone cannot account for phenobarbital use, liver disease, seizure type or other anticonvulsants.
Food and administration
Zonisamide may be given with or without food unless the veterinarian provides a specific instruction. Giving it consistently in the same routine can help prevent missed doses.
If the dog develops stomach upset, ask whether giving the medication with food would be appropriate.
Why formulation and pharmacy consistency matter
Capsules and compounded formulations can differ. If a compounded liquid is used, confirm the concentration every time it is refilled and measure with an oral syringe.
Do not assume that the same milliliter amount remains correct after a pharmacy change.
What if a dose is missed?
Do not double the next dose automatically. Follow the veterinarian’s instructions based on how late the dose is and when the next dose is due.
See Missed Dog Medication Dose for general principles.
What if an extra dose is given?
Contact the veterinarian with the product strength, amount, dog’s weight, time and other anticonvulsants. Excess exposure can increase sedation and ataxia.
See Dog Got a Double Dose of Medication for what information to gather.
Why zonisamide should not be stopped suddenly without advice
As with other maintenance anticonvulsants, sudden discontinuation can destabilize seizure control. Merck recommends gradual tapering when anticonvulsants are discontinued.
If adverse effects develop, call the veterinarian rather than simply skipping medication for several days.
When seizure control changes after adding phenobarbital
If phenobarbital is added to a dog already taking zonisamide, seizure control may change because phenobarbital can increase zonisamide metabolism. This does not necessarily mean zonisamide has “stopped working.”
The veterinarian may reassess seizure frequency, drug timing and the overall combination plan.
When seizure control changes after stopping phenobarbital
The reverse can also matter. If phenobarbital is gradually removed, zonisamide exposure may change as enzyme induction decreases. That is another reason anticonvulsant transitions should be planned rather than improvised.
Why a seizure diary remains essential
Record every seizure, how long it lasted, whether the dog recovered normally and whether seizures occurred in a cluster. Also record missed doses and major medication changes.
Without a diary, it is surprisingly difficult to know whether a drug reduced seizure frequency by half or whether the last few weeks simply felt calmer.
How to judge whether zonisamide is helping
The treatment goal may be complete seizure freedom, but in many dogs a realistic success is a meaningful reduction in seizure frequency or severity with acceptable side effects.
Quality of life matters. A dog that has fewer seizures but is permanently too sedated to enjoy normal activity may need a different balance.
Cluster seizures and status epilepticus remain emergencies
Zonisamide is a maintenance medication, not a substitute for emergency seizure treatment. Multiple seizures over a short period or a prolonged seizure requires urgent care.
Merck recommends medical intervention for cluster seizures and status epilepticus because of the risks of hyperthermia, hypoxia and brain injury.
Why owners need a rescue plan
If a dog has a history of clusters, ask for a written rescue plan. The veterinarian may prescribe a benzodiazepine or another emergency medication for selected cases.
The plan should state when to administer it, whether it can be repeated and when to leave for an emergency hospital.
Refills and travel deserve advance planning
Long-term anticonvulsant therapy is vulnerable to simple logistical failures. Order refills before the bottle is almost empty, carry extra medication during travel and keep the current pharmacy label with the product.
If another pharmacy supplies a different capsule strength or compounded concentration, verify the instructions before giving it. A formulation change should never be treated as a cosmetic difference.
Why owners should not chase every seizure with an unscheduled extra dose
A breakthrough seizure can be frightening, but zonisamide is a maintenance drug rather than an on-demand rescue medication. Giving extra capsules without a veterinary plan can increase adverse effects without reliably stopping a cluster.
Use the emergency medication and escalation threshold that the veterinarian has specifically prescribed for the dog.
When weight changes may matter
A dog that gains or loses a substantial amount of weight during long-term treatment should be reassessed. The original prescription was chosen for a particular patient at a particular point in time, and major body-weight changes can alter how an existing regimen fits the dog.
Do not recalculate or adjust the medication yourself. Bring the updated weight and seizure diary to the veterinarian so the whole treatment plan can be reviewed.
Why new neurologic signs should not automatically be blamed on the medication
Ataxia and sedation can be drug effects, but circling, persistent head tilt, unequal pupils, progressive weakness or a new personality change can also signal structural brain disease. This is especially important in dogs whose seizures started later in life.
If the neurologic picture changes between seizures, the veterinarian may recommend a new examination or advanced imaging rather than simply reducing medication.
Household consistency reduces errors
When several people care for the same dog, use one written medication log. Mark each dose after it is given rather than before. This prevents both missed doses and the common problem of two family members each assuming the other has not medicated the dog.
For chronic epilepsy, simple routine systems can be as important as knowing the pharmacology.
Why stable routines make treatment easier to evaluate
When meal times, medication times and caregivers change constantly, it becomes harder to understand whether a breakthrough seizure reflects the disease or an inconsistent routine. A predictable schedule does not guarantee control, but it produces cleaner information for the veterinarian.
If work or family commitments make the prescribed schedule unrealistic, discuss that openly. A regimen that fits the household is more likely to be followed correctly over years.
A realistic scenario: add-on treatment for refractory epilepsy
A dog on phenobarbital still has regular seizures despite a therapeutic phenobarbital concentration. Increasing phenobarbital further causes too much sedation. The veterinarian adds zonisamide to target seizures through a different mechanism.
The owner then tracks seizure frequency and coordination over several weeks. That is a common reason an adjunct anticonvulsant enters the plan.
A different scenario: appetite loss after starting zonisamide
A dog begins zonisamide and within days becomes persistently anorexic and lethargic. Waiting several weeks because “side effects should pass” would be inappropriate. The veterinarian may want bloodwork and may change the treatment plan.
When to call the veterinarian
Contact the clinic for persistent appetite loss, repeated vomiting, worsening sedation, marked ataxia, jaundice, urinary changes, increasing seizure frequency or uncertainty after a missed dose.
When urgent care is appropriate
Seek urgent care for status epilepticus, cluster seizures, collapse, severe weakness, inability to stand, suspected large overdose or rapidly worsening neurologic signs.
What owners should track
- dose times and formulation;
- seizure date, duration and recovery;
- appetite and weight;
- sedation and gait;
- vomiting or jaundice;
- urinary changes;
- phenobarbital or other anticonvulsants;
- scheduled laboratory results.
Questions worth asking the veterinarian
- Is zonisamide being used alone or as add-on therapy?
- Does phenobarbital change how zonisamide behaves in my dog?
- What bloodwork do you want before and during treatment?
- What side effects are expected to improve?
- What signs suggest a rare liver or urinary complication?
- What is our emergency plan for cluster seizures?
- How long should we wait before judging whether seizure control has improved?
How this page fits DogMedsHub
This is DogMedsHub’s main medication guide for zonisamide. The Phenobarbital, Levetiracetam and Potassium Bromide pages cover other maintenance anticonvulsants with different monitoring and interaction profiles.
Sources and review notes
The Merck Veterinary Manual review of anticonvulsants describes zonisamide as a sulfonamide-based anticonvulsant used as monotherapy or add-on treatment in dogs, notes its interaction with phenobarbital and lists rare hepatopathy, hypothyroidism, renal tubular acidosis and urinary calculi among reported adverse effects.
Last reviewed: October 2026. DogMedsHub provides source-backed canine medication guidance. This page does not diagnose epilepsy, replace veterinary monitoring or provide an individualized zonisamide dose.
